After closely observing the hepatitis C drug Telaprevir in a study, Vertex Pharmaceuticals Inc., has confirmed that it works well when administered twice daily as well, instead of the earlier believed dosage of thrice daily. The study confirmed that the drug worked in over 80% of the patients when given two times a day as well.
All earlier tests carried out for Telaprevir had reported that the drug had to be given thrice a day, at regular 8 hour intervals, for it to effectively keep hepatitis C under control. The new study, however, has confirmed that even when given twice, at 12 hour intervals, it would work equally well.
81-85% of the patients involved in the study were earlier on a three times a day routine, shifting them to the twice daily routine, in combination with the standard hepatitis C treatments pegylated-interferon and ribavirin sustained the response they gave to the dosage when administered thrice. The data was presented at the meeting of American Association for the Study of Liver Diseases in Boston.
The study has, according to researchers involved, given much better results than initially expected. "I was expecting around 70 percent", Dr Patrick Marcellin, the study's lead investigator, said. The results of the study are being viewed as a big step in the history of hepatitis C treatment.
Popular content
Today's:
All time:
Last viewed:
- GM-Penske Saturn deal falls through; another bidder for Saturn unlikely
- Cisco buys Pure Digital Technologies for $590 million
- Hopes on US economic stimulus package boost Tokyo stocks
- Study: ‘Off-pump’ heart surgery no more effective than conventional ‘on-pump’ surgery
- Wrong-way bets on Australian dollar bring $1.64 billion yearly loss for Citic Pacific
- Authorities Confirm Bird Flu at Canadian Turkey Farm
- CDC Warns of Tamiflu Resistant Flu Bug
- Parallels Desktop 5 for Mac Launched
- Kaplan education unit helps Washington Post swing to profitability in Q2
- 600 Hundred Dogs Confiscated in Washington State
US Business News
- Sony Ericsson shifts HQ from NC to Atlanta; closes a few other sites worldwide
- Microsoft: No-cost Azure service launches in January; to be charged for in February
- Rolls Royce and Air China Close $1.5 Billion Deal for New Engines
- Missouri Plant Work Dispute Resolved by Ford and UAW
- MUFG Looking to Raise $11 Billion Through Public Offering of Common Shares



























